{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T19:30:53Z","timestamp":1758655853812,"version":"3.44.0"},"reference-count":21,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001529","name":"Waikato Medical Research Foundation","doi-asserted-by":"publisher","award":["343"],"award-info":[{"award-number":["343"]}],"id":[{"id":"10.13039\/501100001529","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_pp-2025-0007_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Non-mucinous appendiceal neoplasms (NMAN) are rare. The role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in treating peritoneal dissemination from NMAN is poorly defined. We hypothesise that histology impacts survival and compared the disease characteristics and short- and long-term outcomes of mucinous and non-mucinous appendiceal neoplasms treated with CRS\/HIPEC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_pp-2025-0007_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively reviewed a prospective database of 228 patients with peritoneal disease from appendiceal primaries proceeding to CRS\/HIPEC from 01\/01\/2008 to 30\/06\/2022 at a tertiary referral centre in New\u00a0Zealand.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_pp-2025-0007_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 209 mucinous appendiceal neoplasms (MANs) and 19 NMANs. NMANs were more likely to metastasise to lymph nodes (p&lt;0.001) and be treated with systemic chemotherapy (p&lt;0.001) than MANs. Surgery for NMAN was more likely to involve small bowel resection (p&lt;0.001) and less likely to achieve complete cytoreduction (p&lt;0.001). Short-term outcomes were similar between MAN\u00a0and NMAN. CRS\/HIPEC for NMAN had a major complication\u00a0rate of 15.3\u202f% and no perioperative mortality. Extraperitoneal recurrence, including pleural and systemic recurrence, was more likely to occur in NMAN than all grades of MAN. The median overall survival was not reached in MAN and 16.0\u202fmonths in NMAN. High PCI, ECOG, and tumour grade were associated with poor survival in\u00a0NMAN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_pp-2025-0007_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The prognosis following CRS\/HIPEC for NMAN is poor. Patients with NMAN need to be judiciously selected for CRS\/HIPEC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/pp-2025-0007","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:55:53Z","timestamp":1753160153000},"page":"137-145","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of peritoneal disease arising from mucinous vs. non-mucinous appendiceal neoplasms with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy"],"prefix":"10.1515","volume":"10","author":[{"given":"Rennie Xinrui","family":"Qin","sequence":"first","affiliation":[{"name":"Department of General Surgery, Te Whatu Ora Waikato 3714 , Hamilton , New\u00a0Zealand"},{"name":"Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences , University of Auckland , Auckland , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilisi","family":"Puloka","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Te Whatu Ora Waikato 3714 , Hamilton , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Hui","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Te Whatu Ora Waikato 3714 , Hamilton , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caro","family":"Staheli","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Te Whatu Ora Waikato 3714 , Hamilton , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Te Whatu Ora Waikato 3714 , Hamilton , New\u00a0Zealand"},{"name":"Waikato Clinical Campus, Faculty of Medical and Health Sciences , University of Auckland , Auckland , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simione","family":"Lolohea","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Te Whatu Ora Waikato 3714 , Hamilton , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasen","family":"Ly","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Te Whatu Ora Waikato 3714 , Hamilton , New\u00a0Zealand"},{"name":"Waikato Clinical Campus, Faculty of Medical and Health Sciences , University of Auckland , Auckland , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"2025092318543925714_j_pp-2025-0007_ref_001","doi-asserted-by":"crossref","unstructured":"Bahmad, HF, Aljamal, AA, Alvarez Moreno, JC, Salami, A, Bao, P, Alghamdi, S, et al.. Rising incidence of appendiceal neoplasms over time: does pathological handling of appendectomy specimens play a role? Ann Diagn Pathol 2021;52:151724. https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151724.","DOI":"10.1016\/j.anndiagpath.2021.151724"},{"key":"2025092318543925714_j_pp-2025-0007_ref_002","doi-asserted-by":"crossref","unstructured":"Carr, NJ, Bibeau, F, Bradley, RF, Dartigues, P, Feakins, RM, Geisinger, KR, et al.. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology 2017;71:847\u201358. https:\/\/doi.org\/10.1111\/his.13324.","DOI":"10.1111\/his.13324"},{"key":"2025092318543925714_j_pp-2025-0007_ref_003","doi-asserted-by":"crossref","unstructured":"Govaerts, K, Lurvink, RJ, De Hingh, IHJT, Van der Speeten, K, Villeneuve, L, Kusamura, S, et al.. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 2021;47:11\u201335. https:\/\/doi.org\/10.1016\/j.ejso.2020.02.012.","DOI":"10.1016\/j.ejso.2020.02.012"},{"key":"2025092318543925714_j_pp-2025-0007_ref_004","doi-asserted-by":"crossref","unstructured":"Garach, N, Kusamura, S, Guaglio, M, Bartolini, V, Deraco, M, Baratti, D. Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol The journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Internet] 2021;47:1132. https:\/\/doi.org\/10.1016\/j.ejso.2020.08.017.","DOI":"10.1016\/j.ejso.2020.08.017"},{"key":"2025092318543925714_j_pp-2025-0007_ref_005","doi-asserted-by":"crossref","unstructured":"Zambrano-Vera, K, Sardi, A, Munoz-Zuluaga, C, Studeman, K, Nieroda, C, Sittig, M, et al.. Outcomes in peritoneal carcinomatosis from appendiceal goblet cell carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC). Ann Surg Oncol 2020;27:179\u201387. https:\/\/doi.org\/10.1245\/s10434-019-07932-5.","DOI":"10.1245\/s10434-019-07932-5"},{"key":"2025092318543925714_j_pp-2025-0007_ref_006","doi-asserted-by":"crossref","unstructured":"Uemura, M, Qiao, W, Fournier, K, Morris, J, Mansfield, P, Eng, C, et al.. Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery. BMC Cancer 2017;17:1\u20138. https:\/\/doi.org\/10.1186\/s12885-017-3327-0.","DOI":"10.1186\/s12885-017-3327-0"},{"key":"2025092318543925714_j_pp-2025-0007_ref_007","doi-asserted-by":"crossref","unstructured":"Tsagkalidis, V, Choe, JK, Beninato, T, Eskander, MF, Grandhi, MS, In, H, et al.. Extent of resection and long-term outcomes for appendiceal adenocarcinoma: a SEER database analysis of mucinous and non-mucinous histologies. Ann Surg Oncol 2024;31:4203\u201312. https:\/\/doi.org\/10.1245\/s10434-024-15233-9.","DOI":"10.1245\/s10434-024-15233-9"},{"key":"2025092318543925714_j_pp-2025-0007_ref_008","doi-asserted-by":"crossref","unstructured":"McClelland, PH, Gregory, SN, Nah, SK, Hernandez, JM, Davis, JL, Blakely, AM. Predicting survival in mucinous adenocarcinoma of the appendix: demographics, disease presentation, and treatment methodology. Ann Surg Oncol 2024;31:6237. https:\/\/doi.org\/10.1245\/s10434-024-15526-z.","DOI":"10.1245\/s10434-024-15526-z"},{"key":"2025092318543925714_j_pp-2025-0007_ref_009","doi-asserted-by":"crossref","unstructured":"Qin, RX, Lim, JH, Ly, J, Fischer, J, Smith, N, Karalus, M, et al.. Long-term survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Waikato, Aotearoa New\u00a0Zealand: a 12-year experience. ANZ J Surg 2024;94:621. https:\/\/doi.org\/10.1111\/ans.18777.","DOI":"10.1111\/ans.18777"},{"key":"2025092318543925714_j_pp-2025-0007_ref_010","doi-asserted-by":"crossref","unstructured":"Sugarbaker, PH. Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy. Tech Coloproctol 2005;9:95\u2013103. https:\/\/doi.org\/10.1007\/s10151-005-0205-6.","DOI":"10.1007\/s10151-005-0205-6"},{"key":"2025092318543925714_j_pp-2025-0007_ref_011","doi-asserted-by":"crossref","unstructured":"Jacquet, P, Sugarbaker, PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82:359\u201374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23.","DOI":"10.1007\/978-1-4613-1247-5_23"},{"key":"2025092318543925714_j_pp-2025-0007_ref_012","unstructured":"WHO Classification of Tumours Editorial Board. Digestive system tumours. In: WHO classification of tumours, 5th ed. Geneva, Switzerland: World Health Organization. Available from: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Digestive-System-Tumours-2019."},{"key":"2025092318543925714_j_pp-2025-0007_ref_013","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman, O. Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study. J\u00a0Comp Eff Res 2020;9:431. https:\/\/doi.org\/10.2217\/cer-2019-0179.","DOI":"10.2217\/cer-2019-0179"},{"key":"2025092318543925714_j_pp-2025-0007_ref_014","doi-asserted-by":"crossref","unstructured":"O\u2019Connell, J, Hacker, C, Barsky, S. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol An official journal of the United\u00a0States and Canadian Academy of Pathology, Inc [Internet] 2002;15:958. https:\/\/doi.org\/10.1097\/01.mp.0000026617.52466.9f.","DOI":"10.1097\/01.MP.0000026617.52466.9F"},{"key":"2025092318543925714_j_pp-2025-0007_ref_015","doi-asserted-by":"crossref","unstructured":"Yonemura, Y, Kawamura, T, Bandou, E, Tsukiyama, G, Endou, Y, Miura, M. The natural history of free cancer cells in the peritoneal cavity. In: Gonz\u00e1lez-Moreno, S, editor. Advances in peritoneal Surface Oncology. Berlin, Heidelberg: Springer; 2007:11\u201323 pp.","DOI":"10.1007\/978-3-540-30760-0_2"},{"key":"2025092318543925714_j_pp-2025-0007_ref_016","doi-asserted-by":"crossref","unstructured":"Sluiter, NR, van der Bilt, JD, Croll, DMR, Vriens, MR, de Hingh, IHJT, Hemmer, P, et al.. Cytoreduction and hyperthermic intraperitoneal\u00a0chemotherapy (HIPEC) versus surgery without\u00a0HIPEC\u00a0for goblet-cell carcinoids and mixed adenoneuroendocrine\u00a0carcinomas: propensity score\u2013matched analysis of centers in The Netherlands and Belgium. Clin Colorectal Cancer 2020;19:e87\u201399. https:\/\/doi.org\/10.1016\/j.clcc.2020.01.002.","DOI":"10.1016\/j.clcc.2020.01.002"},{"key":"2025092318543925714_j_pp-2025-0007_ref_017","doi-asserted-by":"crossref","unstructured":"Hallam, S, Tyler, R, Price, M, Beggs, A, Youssef, H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open 2019;3:585\u201394. https:\/\/doi.org\/10.1002\/bjs5.50179.","DOI":"10.1002\/bjs5.50179"},{"key":"2025092318543925714_j_pp-2025-0007_ref_018","doi-asserted-by":"crossref","unstructured":"Yu, HH, Yonemura, Y, Hsieh, MC, Mizumoto, A, Wakama, S, Lu, CY. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center. Cancer Manage Res 2017;9:513. https:\/\/doi.org\/10.2147\/cmar.s147227.","DOI":"10.2147\/CMAR.S147227"},{"key":"2025092318543925714_j_pp-2025-0007_ref_019","doi-asserted-by":"crossref","unstructured":"Mercier, F, Passot, G, Bonnot, PE, Cashin, P, Ceelen, W, Decullier, E, et al.. An international registry of peritoneal carcinomatosis from appendiceal\u00a0goblet cell carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg 2022;46:1. https:\/\/doi.org\/10.1007\/s00268-022-06498-w.","DOI":"10.1007\/s00268-022-06498-w"},{"key":"2025092318543925714_j_pp-2025-0007_ref_020","doi-asserted-by":"crossref","unstructured":"Palmer, K, Weerasuriya, S, Chandrakumaran, K, Rous, B, White, BE, Paisey, S, et al.. Goblet cell adenocarcinoma of the appendix: a systematic review and incidence and survival of 1,225 cases from an English cancer registry. Front Oncol 2022;12:915028. https:\/\/doi.org\/10.3389\/fonc.2022.915028.","DOI":"10.3389\/fonc.2022.915028"},{"key":"2025092318543925714_j_pp-2025-0007_ref_021","doi-asserted-by":"crossref","unstructured":"Raghav, KPS, Shetty, AV, Kazmi, SMA, Zhang, N, Morris, J, Taggart, M, et al.. Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist 2013;18:1270. https:\/\/doi.org\/10.1634\/theoncologist.2013-0186.","DOI":"10.1634\/theoncologist.2013-0186"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0007\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0007\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T18:54:54Z","timestamp":1758653694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0007\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,23]]},"published-print":{"date-parts":[[2025,9,24]]}},"alternative-id":["10.1515\/pp-2025-0007"],"URL":"https:\/\/doi.org\/10.1515\/pp-2025-0007","relation":{},"ISSN":["2364-7671","2364-768X"],"issn-type":[{"type":"print","value":"2364-7671"},{"type":"electronic","value":"2364-768X"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}